These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3913808)

  • 1. [Minipress in congestive heart failure].
    Chlewicka I; Torbicki A; Maciejewska M
    Kardiol Pol; 1985; 28(10):622-7. PubMed ID: 3913808
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure].
    Kersting F; Samosny G; Kasper W; Schuster HP
    Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
    Szmydt W; Kaftańska A; Paradowski S
    Pol Tyg Lek; 1984 Nov; 39(46):1509-12. PubMed ID: 6393093
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic effects and clinical observations on prazosin in treating chronic refractory congestive heart failure].
    Shen LH; Ku FS; Liu QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):244-7, 315. PubMed ID: 6544203
    [No Abstract]   [Full Text] [Related]  

  • 10. [Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Froer KL; Hall D; Rudolph W
    Herz; 1983 Apr; 8(2):81-7. PubMed ID: 6343211
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Kuhn H; Boch H; Lösse B
    Z Kardiol; 1981 Jul; 70(7):501-7. PubMed ID: 7269730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prazosin in heart insufficiency. Short-term hospital clinical trial].
    Sánchez Domińguez J; González Villa J; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Mar; 160(6):371-6. PubMed ID: 7255801
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of minipress in hypertension].
    Liusov VA; Bakhshaliev AB; Savenkov PM; Evsikov EM; Gadzhiev RF
    Sov Med; 1989; (11):52-5. PubMed ID: 2697090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prazosin in the treatment of chronic cardiac failure (author's transl)].
    Lanfranchi J; Sachs RN
    Ann Cardiol Angeiol (Paris); 1982; 31(2):133-7. PubMed ID: 7049045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy].
    Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haemodynamic effects and plasma concentrations of prazosin in chronic heart failure (author's transl)].
    Pornin M; Decourt S; Sellier P; Guermonprez JL; Ourbak P; Maurice P; Flouvat B
    Therapie; 1981; 36(4):435-42. PubMed ID: 7292426
    [No Abstract]   [Full Text] [Related]  

  • 19. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.